CURE Pharmaceutical Competitors and Similar CompaniesClear all
CURE Pharmaceutical's competitors and similar companies include Biogen and Livzon Pharmaceutical Group.
 Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | ||
Founding Date | Founding Date 2011 | Founding Date 1978 | Founding Date 1985 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Oxnard, US HQ | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN |
Employees | Employees 15 | Employees 7,605 | Employees 9,067 |
Valuation ($) | Valuation ($) 104.7 m | Valuation ($) 26.7 b | Valuation ($) 4.2 b |
Financial | |||
Revenue (est.) | Revenue (est.) $4.3m (FY, 2023) | Revenue (est.) $9.9b (FY, 2025) | Revenue (est.) ¥11.7b (FY, 2025) |
Cost of goods | Cost of goods $1.2m (FY, 2023) | Cost of goods $2.4b (FY, 2025) | Cost of goods ¥4.1b (FY, 2025) |
Gross profit | Gross profit $3.1m (FY, 2023) | Gross profit $7.5b (FY, 2025) | Gross profit ¥7.8b (FY, 2025) |
Net income | Net income ($3.4m) (FY, 2023) | Net income $1.3b (FY, 2025) | Net income ¥2.4b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Biogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View companyLivzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View company